Founder & CEO
Prof. AdilMardinoglu
A systems biologist who spent his career asking one question: what would medicine look like if it could read the whole person? Phenome is his answer.
Professor at King’s College London and KTH Royal Institute of Technology
- 300+Published papers
- 52,000+Citations
- 25+Researchers in his team
- 3+Biotech companies founded
2 Decades of Science
Systems Biology, Multi-Omics and AI, brought out of the lab and into the hands of everyone who wants to understand their health.
His work
Prof. Mardinoglu works at the meeting point of multi-omics, big biological data, AI and Systems Biology. He has been a key contributor to the Human Protein Atlas, one of the largest biological databases in the world, and he directs the Global 1 Million Phenome Initiative.
Before Phenome Longevity, he founded ScandiBio Therapeutics, ScandiEdge Therapeutics and Trustlife Therapeutics. Phenome Longevity brings that research to people directly with our own Clinics, Omics Labs, Supplements, Devices, App & AI, all built for the same individual.
“We generate more than a billion data points for each person. The goal is simple: see disease coming years before it arrives.”
As featured in Nature
The longevity opportunity: AI meets big biological data
Nature’s feature on how datasets from diverse populations and AI could help people live longer, healthier lives, with Prof. Leroy Hood, Prof. Mathias Uhlen and Prof. Adil Mardinoglu.
Selected work
Genome-scale models in human metabologenomics
Nature Reviews Genetics · 2025
Longitudinal big biological data in the AI era
Molecular Systems Biology · 2025